NSF Org:	TI Translational Impacts
Recipient:	EYE-PREDICT LLC
Initial Amendment Date:	August 10, 2020
Latest Amendment Date:	January 20, 2022
Award Number:	2014693
Award Instrument:	Standard Grant
Program Manager:	Alastair Monk amonk@nsf.gov  (703)292-4392 TI  Translational Impacts TIP  Directorate for Technology, Innovation, and Partnerships
Start Date:	August 1, 2020
End Date:	February 28, 2022 (Estimated)
Total Intended Award Amount:	$225,000.00
Total Awarded Amount to Date:	$225,000.00
Funds Obligated to Date:	FY 2020 = $225,000.00
History of Investigator:	Ran Carmi (Principal Investigator) carmi@eye-predict.com
Recipient Sponsored Research Office:	Eye-Predict 3400 BEN LOMOND PL APT 301 LOS ANGELES CA  US  90027-2955 (626)376-4804
Sponsor Congressional District:	30
Primary Place of Performance:	Eye-Predict 3400 BEN LOMOND PL STE 301 LOS ANGELES CA  US  90027-2955
Primary Place of Performance Congressional District:	30
Unique Entity Identifier (UEI):	EMT6N5RHL8C5
Parent UEI:
NSF Program(s):	SBIR Phase I
Primary Program Source:	01002021DB NSF RESEARCH & RELATED ACTIVIT
Program Reference Code(s):	090E, 8018, 8032, 8033, 8089
Program Element Code(s):	537100
Award Agency Code:	4900
Fund Agency Code:	4900
Assistance Listing Number(s):	47.084

ABSTRACT

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I is better outcomes and lower costs for people with major neurological or psychiatric conditions. The proposed technology will offer a set of tests for assessment of cognitive function. Millions of Americans suffer persistent emotional, cognitive, or sensorimotor dysfunction after experiencing traumatic brain injury. The proposed system will operate on standard mobile devices to facilitate easy diagnosis and treatment.

This Small Business Innovation Research (SBIR) Phase I project will establish the feasibility of developing a battery of visuotactile tests to assess mental domains. The proposed study will yield stimulus-response data (psychometric functions) based on novel visuotactile measures and compare them to analogous functions based on gold-standard measures that are much less accessible. Personalized testing will maximize interpretability by customizing stimulus parameters for each individual and testing session, thus minimizing the likelihood of floor and ceiling effects. The feasibility aims will be achieved if psychometric trends for the proposed measures match those found for analogous gold-standard measures.

This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

PROJECT OUTCOMES REPORT

Disclaimer

This Project Outcomes Report for the General Public is displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed in this Report are those of the PI and do not necessarily reflect the views of the National Science Foundation; NSF has not approved or endorsed its content.

Overview       

This project resulted in a novel test battery that leverages touchscreens and finger gestures to assess mental function. This battery is designed to offer a superior combination of validity and accessibility compared to alternatives. Testing reports could inform intervention decisions for post-injury patients, leading to improved outcomes and lower costs if better decisions are made. 

Intellectual Merit

This Small Business Innovation Research (SBIR) Phase I project established the feasibility of developing and using visuotactile tests to emulate less accessible eyegaze tests of mental function by demonstrating equivalent stimulus-response functions for clinically relevant measures. This finding justifies the larger investment that would be needed to demonstrate clinically meaningful accuracy, precision, and reliability.

Broader Impacts

This SBIR project established the feasibility of using a novel test battery based on accessible visuotactile measures to meet assessment needs in health, educational, and professional settings. The initial target application is to inform intervention decisions for the millions of individuals who suffer from persistent dysfunction and symptoms following traumatic injuries. Rapid test deployment to diverse settings will be facilitated by a software-as-a-service framework and free trial periods. Successful commercialization will result in a large-scale testing database and enable synergistic applications, such as visuotactile training to improve mental function.

Last Modified: 08/05/2022
Modified by: Ran Carmi

Please report errors in award information by writing to: awardsearch@nsf.gov.